Zevra Therapeutics, Inc. ZVRA Return on invested capital

Return on invested capital at other companies

BioMarin PharmaceuticalsBMRN

1.5%-9.2pp

Ultragenyx PharmaceuticalRARE

-475.4%+443pp

RFL

Rafael Holdings, Inc.RFL

-109.2%-147pp

XER

Xeris Biopharma Holdings, Inc.XERS

21.7%+17.8pp

Theravance BiopharmaTBPH

1.5%+0.8pp

Eton Pharmaceuticals, Inc.ETON

-45.1%-22.2pp

FAQ

What is Zevra Therapeutics, Inc.'s return on invested capital?

Zevra Therapeutics, Inc. (ZVRA) reported return on invested capital of 71.7% in Q2 2026.

How has Zevra Therapeutics, Inc.'s return on invested capital changed year-over-year?

Zevra Therapeutics, Inc.'s return on invested capital increased by 211.1% year-over-year, from -64.6% to 71.7%.

What is the long-term trend for Zevra Therapeutics, Inc.'s return on invested capital?

Over 2 years (2023 to 2025), Zevra Therapeutics, Inc.'s return on invested capital has grown at a -57.5% compound annual growth rate (CAGR), from -276.6% to -49.9%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.